WHO chief scientist welcomes India’s decision to restart COVID-19 vaccine exports

New Delhi: Chief scientist of World Health Organization (WHO) Dr Soumya Swaminathan on Tuesday welcomed India’s decision to restart COVID-19 vaccine exports. She said that the decision will go long way to achieve global Vaccine Equity.

“COVAX welcomes the decision to restart Covid vaccine exports. Will go a long way to achieve global Vaccine Equity,” Soumya Swaminathan said in a tweet.

Union Minister of Health and Family Welfare Mansukh Mandaviya on Monday announced that in the fourth quarter this year, the Government of India will resume Vaccine Maitri, an initiative to provide Covid vaccines to countries around the world and also fulfil its responsibility under Covax.

“Under Vaccine Maitri, we will help the world and contribute to Covax in the fourth quarter,” Mandaviya said to reporters. He also announced that next month government is expecting more than 30 crore doses from vaccine manufacturers.

Health Minister estimated the target of the fourth quarter this year to be around 100 crores and highlighted that vaccination of own citizens is the topmost priority.

Meanwhile, with the administration of 96,46,778 vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage exceeded 81.85 crores (81,85,13,827) as per provisional reports till 7 am on Tuesday, informed the Ministry of Health and Family Welfare.

The ministry said that this has been achieved through 80,35,135 sessions.

As per the data, as many as 1,03,69,386 healthcare workers have been inoculated with the first dose of COVID vaccine while 87,50,107 have been inoculated with both doses. The number of frontline workers vaccinated stands at 1,83,46,016 (first dose) and 1,45,66,593 (two doses).

Early this year, India halted vaccine exports as coronavirus cases surged in the country.

  • Related Posts

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    New Delhi: The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has issued four price-related notifications dated November 2, 2026, covering the fixation…

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    During the raid, the accused were allegedly found storing medicines and pharmaceutical drugs without valid licences, permits or authorisations and replacing labels on the stored medicines. The Directorate of Enforcement…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Medicines that cure Us are making Our Environment Sick

    Medicines that cure Us are making Our Environment Sick

    ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

    ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

    PGIMS recalls drug amid probe into deaths

    PGIMS recalls drug amid probe into deaths